Enzyme replacement therapy has shown promise against these conditions4,5, but wider interest lies in whether LCAT activity and the underlying RCT mechanisms can be harnessed against atherosclerosis, which is caused by the build-up of arterial plaques comprised of cholesterol, fatty material, calcium and other components. The gene discussed is LCAT; the disease is atherosclerosis.